MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Orna Therapeutics
Organization & Developments: Orna Therapeutics
Parents
Orna Therapeutics
Children
2021: Orna Therapeutics debuts with $100M, engineered circular RNA treatments to rival cell therapies
2026: Lilly buys Orna in $2.4B deal to enter in vivo CAR-T arena
Wesselhoeft and his MIT colleagues figured out how to make oRNAs express proteins despite not having a cap for ribosomes to latch onto, a means of expression that can result in much higher levels of protein than a linear RNA
Jumps
Finance & Acquisitions: Orna Therapeutics
Key People: Orna Therapeutics